482 related articles for article (PubMed ID: 19059942)
1. Antifungal mechanisms supporting boric acid therapy of Candida vaginitis.
De Seta F; Schmidt M; Vu B; Essmann M; Larsen B
J Antimicrob Chemother; 2009 Feb; 63(2):325-36. PubMed ID: 19059942
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of bergamot natural essence and furocoumarin-free and distilled extracts, and their associations with boric acid, against clinical yeast isolates.
Romano L; Battaglia F; Masucci L; Sanguinetti M; Posteraro B; Plotti G; Zanetti S; Fadda G
J Antimicrob Chemother; 2005 Jan; 55(1):110-4. PubMed ID: 15574476
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of fluconazole on Candida albicans.
Abecia LC; Arévalo JM; López MJ
Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
[TBL] [Abstract][Full Text] [Related]
4. Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors.
Kalkanci A; Güzel AB; Khalil II; Aydin M; Ilkit M; Kuştimur S
Med Mycol; 2012 Aug; 50(6):585-93. PubMed ID: 22369624
[TBL] [Abstract][Full Text] [Related]
5. Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates.
Naidu AS; Fowler RS; Martinez C; Chen J; Tulpinski J
J Reprod Med; 2004 Oct; 49(10):800-7. PubMed ID: 15568403
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
[TBL] [Abstract][Full Text] [Related]
7. Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis.
Cernicka J; Subik J
Int J Antimicrob Agents; 2006 May; 27(5):403-8. PubMed ID: 16621465
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of Candida species isolated from female prostitutes with vulvovaginitis to antifungal agents and boric acid.
Otero L; Fleites A; Méndez FJ; Palacio V; Vázquez F
Eur J Clin Microbiol Infect Dis; 1999 Jan; 18(1):59-61. PubMed ID: 10192716
[TBL] [Abstract][Full Text] [Related]
9. Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents.
Redondo-Lopez V; Lynch M; Schmitt C; Cook R; Sobel JD
Obstet Gynecol; 1990 Oct; 76(4):651-5. PubMed ID: 2216197
[TBL] [Abstract][Full Text] [Related]
10. Antifungal activity of local anesthetics against Candida species.
Pina-Vaz C; Rodrigues AG; Sansonetty F; Martinez-De-Oliveira J; Fonseca AF; Mårdh PA
Infect Dis Obstet Gynecol; 2000; 8(3-4):124-37. PubMed ID: 10968594
[TBL] [Abstract][Full Text] [Related]
11. Boric Acid and Commercial Organoboron Products as Inhibitors of Drug-Resistant Candida albicans.
Larsen B; Petrovic M; De Seta F
Mycopathologia; 2018 Apr; 183(2):349-357. PubMed ID: 28993976
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study.
Lamfon H; Porter SR; McCullough M; Pratten J
J Antimicrob Chemother; 2004 Feb; 53(2):383-5. PubMed ID: 14729749
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model.
Lignell A; Löwdin E; Cars O; Sjölin J
J Antimicrob Chemother; 2008 Jul; 62(1):142-8. PubMed ID: 18408237
[TBL] [Abstract][Full Text] [Related]
14. Differential Response of
Salama OE; Gerstein AC
Antimicrob Agents Chemother; 2022 May; 66(5):e0240621. PubMed ID: 35446135
[TBL] [Abstract][Full Text] [Related]
15. Novel Preclinical Study of Galloylquinic Acid Compounds from
Al-Madboly LA; Abd El-Salam MA; Bastos JK; El-Shorbagy SH; El-Morsi RM
Microbiol Spectr; 2022 Oct; 10(5):e0272421. PubMed ID: 35972130
[TBL] [Abstract][Full Text] [Related]
16. Activated lactoferrin's ability to inhibit Candida growth and block yeast adhesion to the vaginal epithelial monolayer.
Naidu AS; Chen J; Martinez C; Tulpinski J; Pal BK; Fowler RS
J Reprod Med; 2004 Nov; 49(11):859-66. PubMed ID: 15603095
[TBL] [Abstract][Full Text] [Related]
17. In vitro assessment of gentian violet anti- candida activity.
Gomes-de-Elvas AR; Palmeira-de-Oliveira A; Gaspar C; Gouveia P; Palmeira-de-Oliveira R; Pina-Vaz C; Rodrigues AG; Martinez-de-Oliveira J
Gynecol Obstet Invest; 2012; 74(2):120-4. PubMed ID: 22889741
[TBL] [Abstract][Full Text] [Related]
18. Fungicidal activity of miconazole against Candida spp. biofilms.
Vandenbosch D; Braeckmans K; Nelis HJ; Coenye T
J Antimicrob Chemother; 2010 Apr; 65(4):694-700. PubMed ID: 20130024
[TBL] [Abstract][Full Text] [Related]
19. Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy.
Shahid Z; Sobel JD
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):354-6. PubMed ID: 19501794
[TBL] [Abstract][Full Text] [Related]
20. Antifungal activity of Morinda citrifolia fruit extract against Candida albicans.
Jainkittivong A; Butsarakamruha T; Langlais RP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):394-8. PubMed ID: 19716507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
